Recent findings from a comprehensive review published in a prominent medical journal indicate that taking paracetamol during pregnancy is safe and does not elevate the risk of autism, ADHD, or other developmental challenges in children. This analysis contradicts earlier assertions made by former President Donald Trump, which stirred concern among expectant mothers and healthcare professionals worldwide.
Experts advocate for the reassurance these findings provide, as they reinforce guidance from major health organizations regarding the use of this common painkiller during pregnancy. With the evidence at hand, pregnant women can navigate their pain management choices more confidently.
Key Developments
- A review published in The Lancet analyzed 43 robust studies on paracetamol use during pregnancy, involving hundreds of thousands of women.
- Lead researcher Professor Asma Khalil reported no evidence linking paracetamol to autism or ADHD in children.
- The review utilized sibling studies to eliminate biases related to genetics and family environment.
- Health experts commend the review’s findings, believing it alleviates undue stress among pregnant women regarding pain management.
- Contradictory claims from former President Trump suggested a link between paracetamol and autism, which have been challenged by the latest research.
Full Report
Conflicting Claims Addressed
The recent review sought to alleviate concerns raised by previous statements from former President Trump, who controversially linked paracetamol, known as acetaminophen in the U.S., to autism risks. His remarks led to widespread confusion among both pregnant women and health professionals. Medical organizations worldwide criticized these claims, defending the drug’s safety as a pain relief option for expectant mothers.
Study Findings
The rigorous review analyzed high-quality studies to assess the safety of paracetamol during pregnancy. By focusing on sibling comparisons, researchers were able to control for environmental and genetic variables that could skew results. According to Professor Khalil, the analysis revealed no association between paracetamol use during pregnancy and the development of autism or ADHD in children. This reinforces existing recommendations from health bodies in the U.S., UK, and Europe regarding pain management for pregnant women.
Health Implications
Medical experts highlight the importance of managing fever or pain during pregnancy, citing the potential risks associated with untreated conditions, including miscarriage or developmental issues in infants. Several professionals expressed hope that the results of this review will alleviate unnecessary anxiety among expectant mothers who rely on paracetamol for pain relief.
Reactions from the Medical Community
Experts not involved in the study welcomed its findings, asserting that it brings clarity to a subject that has caused concern and uncertainty among pregnant women. Notable figures in maternal health praised the study’s methodology, emphasizing its reliability and the clarity it brings to potential risks associated with paracetamol use.
Context & Previous Events
In September 2025, President Trump claimed a connection between paracetamol use during pregnancy and an increased risk of autism in children. His administration’s comments prompted a wave of criticism from medical experts. Earlier reviews, including one led by Dr. Andrew Baccarelli from Harvard, focused on potential links between acetaminophen use in pregnancy and developmental disorders, urging caution regarding heavy or prolonged use. Despite this, the FDA has maintained that a causal relationship between paracetamol and neurological issues has not been established, asserting it remains a safe choice for treating fever during pregnancy.
